CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Preferred Stock Series B Preferred Stock	Preferred Stock Series A Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2023	$ 0	$ 0	$ 14,897	$ 6,917,774	$ (8,960,981)	$ (2,028,310)
Shares, Outstanding, Beginning Balance at Dec. 31, 2023	0	0	14,896,791
NET LOSS	$ 0	$ 0	$ 0	0	(425,942)	(425,942)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2024	$ 0	$ 0	$ 14,897	6,917,774	(9,386,923)	(2,454,252)
Shares, Outstanding, Ending Balance at Mar. 31, 2024	0	0	14,896,791
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2023	$ 0	$ 0	$ 14,897	6,917,774	(8,960,981)	(2,028,310)
Shares, Outstanding, Beginning Balance at Dec. 31, 2023	0	0	14,896,791
Common stock issued to settle accounts payable and accrued expenses						26,250
NET LOSS						(1,356,761)
Equity, Attributable to Parent, Ending Balance at Sep. 30, 2024	$ 0	$ 0	$ 5,482	6,953,439	(10,317,742)	(3,358,821)
Shares, Outstanding, Ending Balance at Sep. 30, 2024	0	0	5,481,619
Common stock issued to settle accrued expenses - related party						0
Common stock issued to settle accrued interest						0
Exchange of common stock for Series A Preferred Stock						9,794
Equity, Attributable to Parent, Beginning Balance at Mar. 31, 2024	$ 0	$ 0	$ 14,897	6,917,774	(9,386,923)	(2,454,252)
Shares, Outstanding, Beginning Balance at Mar. 31, 2024	0	0	14,896,791
NET LOSS	$ 0	$ 0	$ 0	0	(470,675)	(470,675)
Equity, Attributable to Parent, Ending Balance at Jun. 30, 2024	$ 0	$ 0	$ 14,897	6,917,774	(9,857,598)	(2,924,927)
Shares, Outstanding, Ending Balance at Jun. 30, 2024	0	0	14,896,791
Common stock issued to settle accounts payable and accrued expenses	$ 0	$ 0	$ 379	25,871	0	26,250
Common stock issued to settle accounts payable and accrued expenses, shares			378,582
NET LOSS	0	0	$ 0	0	(460,144)	(460,144)
Equity, Attributable to Parent, Ending Balance at Sep. 30, 2024	$ 0	$ 0	$ 5,482	6,953,439	(10,317,742)	(3,358,821)
Shares, Outstanding, Ending Balance at Sep. 30, 2024	0	0	5,481,619
Exchange of common stock for Series A Preferred Stock	$ 0	$ 0	$ (9,794)	9,794	0	0
Exchange of common stock for Series A Preferred Stock Shares		0	(9,793,754)
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2024	$ 200	$ 0	$ 39,991	7,374,297	(10,809,256)	(3,394,768)
Shares, Outstanding, Beginning Balance at Dec. 31, 2024	200,000	0	39,990,903
Common stock issued to settle accounts payable and accrued expenses	$ 0	$ 0	$ 5,253	143,941	0	149,194
Common stock issued to settle accounts payable and accrued expenses, shares			5,253,234
NET LOSS	0				(591,397)	(591,397)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2025	$ 200	$ 0	$ 45,244	7,518,238	(11,400,653)	(3,836,971)
Shares, Outstanding, Ending Balance at Mar. 31, 2025	200,000	0	45,244,137
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2024	$ 200	$ 0	$ 39,991	7,374,297	(10,809,256)	(3,394,768)
Shares, Outstanding, Beginning Balance at Dec. 31, 2024	200,000	0	39,990,903
Common stock issued to settle accounts payable and accrued expenses						330,431
NET LOSS						(1,607,467)
Equity, Attributable to Parent, Ending Balance at Sep. 30, 2025	$ 200	$ 0	$ 318,890	8,212,004	(12,416,723)	(3,885,629)
Shares, Outstanding, Ending Balance at Sep. 30, 2025	200,000	0	318,890,559
Common stock issued to settle accrued expenses - related party	$ 0	$ 0	$ 75,000	150,000	0	$ 225,000
Common stock issued to settle accrued expenses - related party			75,000,000			75,000,000
Common stock issued to settle accrued interest						$ 323,453
Common stock issued to settle accrued interest			38,971,457
Exchange of common stock for Series A Preferred Stock						0
Equity, Attributable to Parent, Beginning Balance at Mar. 31, 2025	$ 200	$ 0	$ 45,244	7,518,238	(11,400,653)	(3,836,971)
Shares, Outstanding, Beginning Balance at Mar. 31, 2025	200,000	0	45,244,137
Common stock issued to settle accounts payable and accrued expenses	$ 0	$ 0	$ 6,381	108,429	0	114,810
Common stock issued to settle accounts payable and accrued expenses, shares			6,380,952
NET LOSS	0	0	$ 0	0	(486,149)	(486,149)
Equity, Attributable to Parent, Ending Balance at Jun. 30, 2025	$ 200	$ 0	$ 51,625	7,626,667	(11,886,802)	(4,208,310)
Shares, Outstanding, Ending Balance at Jun. 30, 2025	200,000	0	51,625,089
Exchange of common stock for Series A Preferred Stock Shares			(9,793,754)
Common stock issued to settle accounts payable and accrued expenses	$ 0	$ 0	$ 29,670	85,837	0	115,507
Common stock issued to settle accounts payable and accrued expenses, shares			29,669,748
NET LOSS	0	0	$ 0	0	(529,921)	(529,921)
Equity, Attributable to Parent, Ending Balance at Sep. 30, 2025	$ 200	$ 0	$ 318,890	8,212,004	(12,416,723)	(3,885,629)
Shares, Outstanding, Ending Balance at Sep. 30, 2025	200,000	0	318,890,559
Common stock issued to settle accrued expenses - related party						225,000
Common stock issued to settle accrued interest	$ 0	$ 0	$ 38,971	102,251	0	141,222
Common stock issued to settle accrued interest			38,971,457
Common stock issued for cash and settlement of accrued interest, net of issuance costs	0	0	$ 106,958	213,915	0	320,873
Common stock issued for cash and settlement of accrued interest, net of issuance costs			106,957,599
Issuance of shares of common stock for cash	$ 0	$ 0	$ 16,666	$ 33,334	$ 0	$ 50,000
Issuance of shares of common stock for cash			16,666,666